Population pharmacokinetics of brexpiprazole in Japanese healthy subjects and patients with schizophrenia

Related articles

1. Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairment

   This article has 15 authors:

   1. Xiaoni Wang
   2. Yunqiu Xie
   3. Xu Zhu
   4. Yuanyuan Xu
   5. Tonghao Zhang
   6. Wang Hu
   7. Qing Wen
   8. Yongdong Zhang
   9. Meijie Le
   10. Jianguo Li
   11. Qifeng Shi
   12. Hui Zhao
   13. Qingfei Wang
   14. Yuanyuan Liu
   15. Huan Zhou

2. Bioequivalence Study of Low-Dose Anagrelide 0.5 mg Capsules under Fasting Conditions in Healthy Turkish Male Subjects

   This article has 8 authors:

   1. Ahmet Inal
   2. Zafer Sezer
   3. Onur Pinarbasli
   4. Burcu Bulut
   5. Martin Reinsch
   6. Wolfgang Martin
   7. Mumtaz M. Mazicioglu
   8. Selma Alime Koru

3. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer’s disease: A Single Ascending-Dose Study in Healthy Participants

   This article has 12 authors:

   1. Alexander C. Conley
   2. Alexandra P. Key
   3. Jennifer U. Blackford
   4. Jason K. Russell
   5. Kimberly M. Albert
   6. Xuewen Gong
   7. Michael Bubser
   8. Jerri M. Rook
   9. P. Jeffrey Conn
   10. Craig W. Lindsley
   11. Carrie K. Jones
   12. Paul A. Newhouse